Dublin, Nov. 25, 2022 (GLOBE NEWSWIRE) -- The "RNA Sequencing Services Market: Distribution by Type of Sequencing Method, Application Area, End User Industry and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.

The 'RNA Sequencing Services Market'' report features an extensive study of the current market landscape and future potential of the RNA sequencing services market. The study also includes an in-depth analysis, highlighting the capabilities of RNA sequencing service providers.

One of the key objectives of the report was to estimate the current market size and the future potential associated with the RNA sequencing services market, over the coming 13 years. We have provided informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035.

Among various sequencing methods, next generation sequencing (NGS) introduced by Lynx Therapeutics in 2000, has emerged as a preferred choice across the industry. It is a high throughput, parallel genome sequencing technology, which enables whole genome and whole exome sequencing. It enables reduction in overall cost and process time.

Despite the various technological advancements in RNA sequencing, there are several existing challenges, including difficulty in sequencing of large genes, shortage of human resources and lack of tools for data manipulation and analysis.

In addition, establishment and maintenance of next generation sequencing based facilities require high capital. In order to overcome these challenges and obtain a high-quality output, the outsourcing of RNA sequencing is considered as a preferable option, among other alternatives, by industry players.

Currently, more than 70 companies offer services related to RNA sequencing. A number of these companies are start-ups that have been established in the past decade. In addition, several stakeholders are engaged in the development of proprietary technologies in order to overcome the errors related to amplification and duplication rates while sequencing.

Further, over 340 patents related to RNA sequencing have been recently filed / granted, which demonstrates the innovation and continuous research efforts in this domain. Moreover, over the last few years, grants worth USD 486 million have been awarded by National Institutes of Health to support the ongoing R&D efforts in this domain.

Driven by the growing interest of various stakeholders and the wide applicability of this technique, we believe that the RNA sequencing services industry is anticipated to witness noteworthy growth in the foreseen future.

Amongst other elements, the report features:

Key Questions Answered

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. An Overview of RNA Sequencing
3.3. Concluding Remarks

4. RNA SEQUENCING SERVICE PROVIDERS: MARKET OVERVIEW
4.1. Chapter Overview
4.1.1. RNA Sequencing Service Providers
4.1.2. Analysis by Year of Establishment
4.1.3. Analysis by Company Size
4.1.4. Analysis by Location of Headquarters
4.1.5. Analysis by Company Size and Region of Headquarters
4.1.6. Analysis by Type of RNA Sequencing Service(s)
4.1.7. Analysis by Type of Platform
4.1.8. Analysis by Turnaround Time
4.1.9. Analysis by Type of Sample
4.1.10. Analysis by Amount of Sample

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Scope and Methodology
5.4. Company Competitiveness Analysis: RNA Sequencing Service Providers in North America
5.5. Company Competitiveness Analysis: RNA Sequencing Service Providers in Europe
5.6. Company Competitiveness Analysis: RNA Sequencing Service Providers in Asia-Pacific and Rest of the World

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Admera Health
6.2.1. Company Overview
6.2.2. RNA Sequencing Service Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Biogazelle (acquired by CellCarta)
6.4. CD Genomics
6.5. Creative Biogene
6.6. IGA Technology
6.7. LC Sciences
6.8. Lexogen
6.9. Novogene
6.10. Otogenetics
6.11. Yaazh Xenomic

7. ACADEMIC GRANT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Analysis by Year of Grant Award

8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. RNA Sequencing: Patent Analysis
8.4. RNA Sequencing: Patent Benchmarking Analysis
8.5. RNA sequencing: Patent Valuation Analysis
8.6. Leading Patents: Analysis by Number of Citations

9. PORTER'S FIVE FORCES ANALYSIS
9.1. Chapter Overview
9.2. Methodology and Assumptions
9.3. Key Parameters
9.4. Concluding Remarks

10. CASE STUDY: NGS LIBRARY PREPARATION KITS
10.1. Chapter Overview
10.2. NGS Library Preparation Kits: Overall Market Landscape
10.3. NGS Library Preparation Kits: Developer Landscape

11. INVESTMENT POTENTIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Profit Potential of Commonly used RNA Sequencing Platforms
11.4. Payback Evaluation Matrix
11.3. Conclusion

12. MARKET SIZING AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global RNA Sequencing Services Market, 2022-2035

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information about this report visit https://www.researchandmarkets.com/r/3m1g6l